Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Assets Average (2016 - 2025)

Historic Assets Average for United Therapeutics (UTHR) over the last 16 years, with Q3 2025 value amounting to $7.6 billion.

  • United Therapeutics' Assets Average rose 1020.34% to $7.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 billion, marking a year-over-year increase of 1020.34%. This contributed to the annual value of $7.3 billion for FY2024, which is 998.75% up from last year.
  • As of Q3 2025, United Therapeutics' Assets Average stood at $7.6 billion, which was up 1020.34% from $7.8 billion recorded in Q2 2025.
  • In the past 5 years, United Therapeutics' Assets Average ranged from a high of $7.8 billion in Q2 2025 and a low of $4.6 billion during Q1 2021
  • Over the past 5 years, United Therapeutics' median Assets Average value was $6.5 billion (recorded in 2023), while the average stood at $6.3 billion.
  • Its Assets Average has fluctuated over the past 5 years, first surged by 2101.56% in 2023, then surged by 103.17% in 2024.
  • Over the past 5 years, United Therapeutics' Assets Average (Quarter) stood at $5.1 billion in 2021, then rose by 15.74% to $5.9 billion in 2022, then grew by 19.99% to $7.1 billion in 2023, then increased by 2.09% to $7.2 billion in 2024, then increased by 5.33% to $7.6 billion in 2025.
  • Its last three reported values are $7.6 billion in Q3 2025, $7.8 billion for Q2 2025, and $7.6 billion during Q1 2025.